Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 19, 2019

Boehringer, Bridge Biotherapeutics sign licence agreement for IPF treatment candidate

Boehringer Ingelheim has signed a new collaboration and licence agreement with Bridge Biotherapeutics to develop autotaxin inhibitor BBT-877 to treat patients with fibrosing interstitial lung diseases.

Continue
Image: Boehringer Ingelheim headquarters in Ingelheim, Germany. Photo: courtesy of Boehringer Ingelheim.
July 18, 2019

FDA approves Merck’s Recarbrio to treat complicated infections

Image: The US FDA’s Center for Drug Evaluation and Research. Photo: courtesy of The U.S. Food and Drug Administration.
July 18, 2019

Astellas signs licensing deal for Frequency’s regenerative drug FX-322

Image: Astellas secures ex-US rights to develop and commercialise FX-322. Photo: courtesy of rawpixel/Pixabay.

Contracts

May 22, 2019

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Image: WuXi Vaccines will build an integrated vaccine manufacturing facility. Photo: courtesy of Arek Socha / Pixabay.

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Deals

Deals July 17, 2019

AbbVie enhances early stage oncology pipeline with acquisition of Mavupharma

Pharmaceutical Business Review

Recordati to acquire worldwide rights to Signifor and Osilodrostat

Boehringer Ingelheim buys Swiss biotech firm AMAL Therapeutics

Altimmune to buy Presidio Partners portfolio firm Spitfire Pharma

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Sensile Medical Develops Innovative Micro-Infusion Pump for EVER Pharma
Sensile Medical Develops Innovative Micro-Infusion Pump for EVER Pharma
Renowned Researchers Leverage Malvern Panalytical’s ASD TerraSpec® Halo Mineral Identifier to Advance Investigation of Life on Mars
Renowned Researchers Leverage Malvern Panalytical’s ASD TerraSpec® Halo Mineral Identifier to Advance Investigation of Life on Mars
Pharmaceutical Business Review
Enclosed Ultrasonic Sieving System for Pharmaceutical Applications
Webinar: Introduction to the GMP Standard for OTC Drug Manufacture NSF/ ANSI 455-4 – 2018
Webinar: Introduction to the GMP Standard for OTC Drug Manufacture NSF/ ANSI 455-4 – 2018
Integrated Industrial Vibratory Sieving Solution for High-Containment Pharmaceutical Production Lines
Integrated Industrial Vibratory Sieving Solution for High-Containment Pharmaceutical Production Lines

Suppliers

Whitepapers

Modern Pharmacovigilance and Regulatory Affairs in the Pharmaceutical Industry
Modern Pharmacovigilance and Regulatory Affairs in the Pharmaceutical Industry
The Biggest Threats to Pharmaceutical Companies
The Biggest Threats to Pharmaceutical Companies
World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market
World’s First CBD of Natural Origin and GMP Pharma Grade Hits the Market